Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Ornithine decarboxylase inhibitor

DRUG CLASS:

Ornithine decarboxylase inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

eflornithine/sulindac (1)

eflornithine (1)

eflornithine (0)

eflornithine/sulindac (1)

eflornithine (1)

eflornithine (0)

›

No biomarker	Neuroblastoma	No biomarker	Neuroblastoma	eflornithine Sensitive: A1 - Approval eflornithine Sensitive : A1	eflornithine Sensitive: A1 - Approval eflornithine Sensitive : A1
No biomarker	Pancreatic Ductal Adenocarcinoma	No biomarker	Pancreatic Ductal Adenocarcinoma	SBP-101 Sensitive: B - Late Trials SBP-101 Sensitive : B	SBP-101 Sensitive: B - Late Trials SBP-101 Sensitive : B
NFATC1 overexpression	Pancreatic Cancer	NFATC1 overexpression	Pancreatic Cancer	eflornithine/sulindac Resistant: D – Preclinical eflornithine / sulindac Resistant : D	eflornithine/sulindac Resistant: D – Preclinical eflornithine / sulindac Resistant : D